Sowell Financial Services LLC Iovance Biotherapeutics, Inc. Transaction History

Sowell Financial Services LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$16.33 - $33.07 $9,716 - $19,676	-595 Closed	0 $0
Q4 2020 Jan 13, 2021	BUY	$28.04 - $50.26 $841 - $1,507	30 Added 5.31%	595 $28,000
Q3 2020 Nov 12, 2020	BUY	$27.75 - $36.3 $4,995 - $6,533	180 Added 46.75%	565 $19,000
Q2 2020 Aug 13, 2020	BUY	$27.21 - $41.0 $10,475 - $15,785	385 New	385 $11,000

314

241M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.28B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.